Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CHRS
Stock Latest News
The Fly
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
5d ago
CHRS
Premium
Ratings
Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
1M ago
CHRS
Premium
The Fly
Coherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trial
1M ago
CHRS
Premium
Company Announcements
Coherus Biosciences Divests UDENYCA Business
2M ago
8K
CHRS
Premium
The Fly
Coherus Oncology files $150M mixed securities shelf
2M ago
CHRS
Premium
Company Announcements
Coherus Biosciences Earnings Call Highlights Strong Growth and Strategic Focus
2M ago
CHRS
Premium
Ratings
Optimistic Buy Rating for Coherus Biosciences Driven by Promising Oncology Pipeline and Strategic Focus
2M ago
CHRS
Premium
Ratings
Coherus Biosciences: Strategic Growth Potential and Strong Market Ambitions Justify Buy Rating
2M ago
CHRS
Premium
The Fly
Coherus Biosciences announces data from Phase 1b trial of CHS-114
2M ago
CHRS
Premium
Company Announcements
Coherus Oncology Reports Q3 2025 Financial Results
2M ago
CHRS
Premium
The Fly
Coherus Biosciences reports Q3 EPS (33c), consensus (29c)
2M ago
CHRS
Premium
Pre-Earnings
CHRS Upcoming Earnings Report: What to Expect?
2M ago
CHRS
Premium
Ratings
Coherus Biosciences: Buy Rating Backed by Innovative Oncology Pipeline and Strategic Transition
3M ago
CHRS
Premium
Company Announcements
Coherus Biosciences Regains Nasdaq Compliance
4M ago
8K
CHRS
Premium
Weekend Updates
Black Diamond, TransMedics, Duolingo, AT&T, Coherus: Trending by Analysts
4M ago
T
BDTX
Premium
The Fly
Coherus Biosciences upgraded to Buy from Neutral at Roth Capital
4M ago
CHRS
Premium
The Fly
Coherus Biosciences upgraded to Buy from Hold at Maxim
4M ago
CHRS
Premium
Company Announcements
Coherus Oncology’s Earnings Call Highlights Growth and Challenges
5M ago
CHRS
Premium
Ratings
Coherus Biosciences: Buy Rating Affirmed Amid Strong Sales Alignment and Promising Pipeline Developments
5M ago
CHRS
Premium
Ratings
Coherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating
5M ago
CHRS
Premium
Company Announcements
Coherus Oncology Reports Strong Q2 2025 Growth
5M ago
CHRS
Premium
The Fly
Coherus Biosciences reports Q2 EPS (39c), consensus (27c)
5M ago
CHRS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
